Increasing demand for point-of-care testing and the potential to incorporate the Internet of medical things in an integrated health management system.
Biosci Trends
; 16(1): 4-6, 2022 Mar 11.
Article
in English
| MEDLINE | ID: covidwho-1705129
ABSTRACT
As the number of people with COVID-19 increases daily around the world, point-of-care testing (POCT) is gaining attention as a tool that can provide immediate test results and greatly help to deter infection and determine what to do next. POCT has several drawbacks such as a low sensitivity and specificity, but according to studies POCT has increased sensitivity on par with that of polymerase chain reaction testing. The advantage of POCT is that the results can be obtained quickly, regardless of the location. To further enhance its benefits, POCT is being developed and researched in conjunction with the Internet of medical things (IoMT), which allows POCT results to be collected, recorded, and managed over a network. IoMT will be beneficial not only for the use of POCT simply as a testing tool but also for its integration into diagnostic and health management systems. IoMT will enable people to regularly receive their test results in their daily lives and to provide personalized diagnosis and treatment of individual conditions, which will be beneficial in terms of disease prevention and maintenance of health.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Diagnostic study
Limits:
Humans
Language:
English
Journal:
Biosci Trends
Journal subject:
Biology
Year:
2022
Document Type:
Article
Affiliation country:
Bst.2022.01074
Similar
MEDLINE
...
LILACS
LIS